Martha Herbert ‏@marthaherbertmd Feb 20 2014
MT - Beyond Hopelessness: Autism as a complex, chronic, whole-body disorder (not a permanent, brain-based trait)

Retweeted by Autism Revolution
Healthy U NOW ‏@HUNFoundation May 15 2013
New detailed article on diet and autism in Journal of Child Neurology- by Drs. Martha Herbert and Julie Buckley! pic.twitter.com/2poXsb3TIJ

[img][/img]

http://www.eurekalert.org/pub_releases/2013-01/niom-sdt011413.php

Public release date: 15-Jan-2013
NIH/National Institute of Mental Health

Study documents that some children lose autism diagnosis
Small group with confirmed autism now on par with mainstream peers -- NIH-funded study

Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has confirmed. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.

The report is the first of a series that will probe more deeply into the nature of the change in these children's status. Having been diagnosed at one time with an autism spectrum disorder (ASD), these young people now appear to be on par with typically developing peers. The study team is continuing to analyze data on changes in brain function in these children and whether they have subtle residual social deficits. The team is also reviewing records on the types of interventions the children received, and to what extent they may have played a role in the transition.

"Although the diagnosis of autism is not usually lost over time, the findings suggest that there is a very wide range of possible outcomes," said NIMH Director Thomas R. Insel, M.D. "For an individual child, the outcome may be knowable only with time and after some years of intervention. Subsequent reports from this study should tell us more about the nature of autism and the role of therapy and other factors in the long term outcome for these children."

The study, led by Deborah Fein, Ph.D., at the University of Connecticut, Storrs, recruited 34 optimal outcome children, who had received a diagnosis of autism in early life and were now reportedly functioning no differently than their mainstream peers. For comparison, the 34 children were matched by age, sex, and nonverbal IQ with 44 children with high-functioning autism, and 34 typically developing peers. Participants ranged in age from 8 to 21 years old.

<>

http://www.protect.org/hero



The H E R O Child Rescue Corps
Published on Dec 10, 2014

Official PROTECT

While America fights terrorists overseas, there is another kind of terrorist right here at home, targeting our children. U.S. law enforcement has identified hundreds of thousands of criminals in the U.S. participating in a global child sexual exploitation marketplace. Now, an elite corps of American military veterans is on a new battlefield, with a new enemy. Watch the video to learn about the crisis and the HERO Corps.

http://www.biotech-now.org/health/2013/09/new-phrma-report-nearly-300-vaccines-currently-in-development

TRACY COOLEY | 09/11/2013
New PhRMA Report: Nearly 300 Vaccines Currently in Development

Today, the Pharmaceutical Research and Manufacturers of America released a report, Medicines in Development: Vaccines – A Report on the Prevention and Treatment of Disease Through Vaccines. The report shows that U.S. biopharma companies are currently developing 271 vaccines to prevent and treat numerous conditions, including infectious diseases and various forms of cancer and neurological disorders.

Vaccines have successfully prevented devastating infectious diseases such as smallpox, measles and polio. According to data from the Centers for Disease Control and Prevention (CDC), 10 infectious diseases have been at least 90 percent eradicated in the U.S. as a result of vaccines. These innovations and subsequent immunization efforts have protected millions of children and families.

“Biopharmaceutical research companies are working with partners across the ecosystem to apply new scientific approaches to the development of both preventative and therapeutic vaccines,” said PhRMA President and CEO John J. Castellani. “The nearly 300 vaccines in the pipeline provide great hope for protecting and improving public health in the United States and across the globe.”

<>